Fundraising Fox

Orig3N

Boston, US · Founded 2014 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

CT
Clay ThorpDirector
KB
Kate BlanchardExecutive Officer, Director, Promoter
DJ
Doug JamisonDirector
JM
Jonathan MeltzerDirector
RY
Robin Y. SmithExecutive Officer, Director, Promoter

Investors · 1

Hatteras Venture PartnersreportedResearch Triangle · $500K – $4M

Reported raises · per SEC filings

Form D private placements
▶$26.2MraisedSep 2020 · 11 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Justin XiangDirector
  • Robin SmithExecutive Officer, Director
  • Kate BlanchardExecutive Officer
  • Dylan DaiDirector
  • Clay ThorpDirector
  • Elona BaumDirector
  • Megann VaughnDirector
  • Byron SmithDirector
Offering amount
$28.7M
Amount sold
$26.2M
First sale
Jun 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.1MraisedDec 2015 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kate BlanchardExecutive Officer, Promoter
  • Robin Y. SmithExecutive Officer, Director, Promoter
  • Tom Mac MahonDirector
  • Clay ThorpDirector
  • Doug JamisonDirector
  • Justin XiangDirector
  • Jonathan MeltzerDirector
  • George HaraDirector
Offering amount
$12.5M
Amount sold
$5.1M
Proceeds to insiders
$438.8K
First sale
Nov 2015
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedFeb 2015 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Clay ThorpDirector
  • Kate BlanchardExecutive Officer, Director, Promoter
  • Doug JamisonDirector
  • Jonathan MeltzerDirector
  • Robin Y. SmithExecutive Officer, Director, Promoter
Offering amount
$3M
Amount sold
$1.5M
Proceeds to insiders
$305.5K
First sale
Feb 2015
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.